-
Study aim
-
Comparison of the effect of misoprostol, vaginal nitroglycerine and capsule of evening primrose evening on cervical ripening in the term pregnancy in Shahid Sayyad Shirazi Hospital in Gorgan
-
Design
-
A clinical trial with a control group, with two groups of parallel intervention, a single-blind, randomized, random block method with a sample size of 201
-
Settings and conduct
-
All pregnant women referring to Sayyad-e-Shirazi Hospital of Gorgan, Iran, were studied by single-blind method and the consequences of this study were measured before and 4 hours after prescribing medications. Measurement of the consequences is performed by gynecology resident who is not informed about intervention and control groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
-Pregnant women (primigravid)
-Term pregnancy (40 weeks onwards)
-Bishop Score less than or equal to 4
-A candidate for induction of childbirth
Exclusion criteria:
History of past uterine surgery
-Use of intrauterine contraceptives (IUD)
-Any medicinal allergy
• Developing systemic and localized infection
• Developing known diseases such as diabetes, hypertension and...
-Existence of any uterine abnormalities.
-
Intervention groups
-
Intervention Group (A): Vaginal nitroglycerin 400 mg of Zahravi company, a dose of 4 to 6 hours to 3 is administered.
Intervention Group (B): Evening primrose Capsules, 1000 mg capsules of primroses (Barij Essence Company with food and drug verification) in a vaginal form every 4 to 6 hours maximum up to 3 doses
The control group (C): 25 mcg of a misoprostol tablet (one-quarter of 100 microgram tablets, Abhan Pharmacy) after humidifying the distilled water every 4to6 hours in vaginal form, maximum of 3 doses
-
Main outcome variables
-
Changes in cervix with Bishop score, newborn Apgar score in one and five minutes, length of time from drug to birth, drug side effects, vaginal bleeding rate